NO168581C - Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer

Info

Publication number
NO168581C
NO168581C NO855353A NO855353A NO168581C NO 168581 C NO168581 C NO 168581C NO 855353 A NO855353 A NO 855353A NO 855353 A NO855353 A NO 855353A NO 168581 C NO168581 C NO 168581C
Authority
NO
Norway
Prior art keywords
thiophenethanamines
methylene
procedure
preparation
therapeutic active
Prior art date
Application number
NO855353A
Other languages
English (en)
Other versions
NO855353L (no
NO168581B (no
Inventor
Thomas M Bargar
Jr Robert Broersma
James R Mccarthy
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO855353L publication Critical patent/NO855353L/no
Publication of NO168581B publication Critical patent/NO168581B/no
Publication of NO168581C publication Critical patent/NO168581C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO855353A 1984-12-31 1985-12-30 Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer NO168581C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68762884A 1984-12-31 1984-12-31

Publications (3)

Publication Number Publication Date
NO855353L NO855353L (no) 1986-07-01
NO168581B NO168581B (no) 1991-12-02
NO168581C true NO168581C (no) 1992-03-11

Family

ID=24761167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855353A NO168581C (no) 1984-12-31 1985-12-30 Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer

Country Status (21)

Country Link
US (1) US4788301A (no)
EP (1) EP0187390B1 (no)
JP (1) JPS61197576A (no)
KR (1) KR900003373B1 (no)
CN (1) CN1006383B (no)
AR (1) AR241137A1 (no)
AT (1) ATE55386T1 (no)
AU (1) AU587591B2 (no)
CA (1) CA1258264A (no)
DE (1) DE3579145D1 (no)
DK (1) DK164504C (no)
ES (1) ES8703866A1 (no)
FI (1) FI81794C (no)
GR (1) GR853149B (no)
HU (1) HU193619B (no)
IE (1) IE58187B1 (no)
NO (1) NO168581C (no)
NZ (1) NZ214698A (no)
PH (1) PH21649A (no)
PT (1) PT81772B (no)
ZA (1) ZA859888B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293511C (en) * 1986-12-23 1991-12-24 James R. Mccarthy Allenyl amines
US4847288A (en) * 1986-12-23 1989-07-11 Merrell Dow Pharmaceuticals Inc. Allenyl amines
US5112852A (en) * 1986-12-23 1992-05-12 Merrell Dow Pharmaceuticals Inc. Allenyl amines
ZA881227B (en) * 1987-02-26 1988-10-26 Merrell Pharma Inc Heterocyclyl-2-propyn-1-amines
RU2464039C2 (ru) * 2008-05-14 2012-10-20 Ипсен Фарма С.А.С. Фармацевтические композиции конъюгатов соматостатин-дофамин

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
FR2508456A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de (thienyl-2)-2 ethylamines et (thienyl-3)-2 ethylamines

Also Published As

Publication number Publication date
FI855158A0 (fi) 1985-12-27
HU193619B (en) 1987-11-30
FI855158A (fi) 1986-07-01
FI81794B (fi) 1990-08-31
NZ214698A (en) 1988-08-30
AU587591B2 (en) 1989-08-24
ES550570A0 (es) 1987-03-01
EP0187390A2 (en) 1986-07-16
FI81794C (fi) 1990-12-10
KR900003373B1 (ko) 1990-05-16
ATE55386T1 (de) 1990-08-15
CN1006383B (zh) 1990-01-10
US4788301A (en) 1988-11-29
AR241137A2 (es) 1991-11-29
EP0187390A3 (en) 1987-03-25
DE3579145D1 (en) 1990-09-13
NO855353L (no) 1986-07-01
DK607785A (da) 1986-07-01
PH21649A (en) 1988-01-13
DK164504B (da) 1992-07-06
NO168581B (no) 1991-12-02
KR860004874A (ko) 1986-07-14
AU5173085A (en) 1986-07-10
IE853326L (en) 1986-06-30
DK164504C (da) 1992-11-23
CN85109434A (zh) 1986-09-24
ZA859888B (en) 1986-09-24
ES8703866A1 (es) 1987-03-01
EP0187390B1 (en) 1990-08-08
PT81772B (pt) 1987-10-20
DK607785D0 (da) 1985-12-30
GR853149B (no) 1986-04-20
JPS61197576A (ja) 1986-09-01
PT81772A (en) 1986-01-02
AR241137A1 (es) 1991-11-29
IE58187B1 (en) 1993-07-28
HUT40099A (en) 1986-11-28
CA1258264A (en) 1989-08-08

Similar Documents

Publication Publication Date Title
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO169126C (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.